{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:09:06Z","timestamp":1776722946486,"version":"3.51.2"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"DOI":"10.7759\/cureus.104698","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:53:37Z","timestamp":1772708017000},"source":"Crossref","is-referenced-by-count":1,"title":["Nitrous Oxide-Induced Myelopathy: A Case From French-Speaking Switzerland"],"prefix":"10.7759","author":[{"given":"Alain","family":"Witzig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"de Massias de Bonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Garin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221082442","article-title":"Increasing recreational nitrous oxide use: should we worry? A narrative review","volume":"36","author":"van Amsterdam JG","year":"2022","unstructured":"van Amsterdam JG, Nabben T, van den Brink W. Increasing recreational nitrous oxide use: should we worry? A narrative review. J Psychopharmacol. 2022, 36:943-50. 10.1177\/02698811221082442","journal-title":"J Psychopharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11120962","article-title":"Nitrous oxide abuse: clinical outcomes, pharmacology, pharmacokinetics, toxicity and impact on metabolism","volume":"11","author":"Gernez E","year":"2023","unstructured":"Gernez E, Lee GR, Niguet JP, Zerimech F, Bennis A, Grzych G. Nitrous oxide abuse: clinical outcomes, pharmacology, pharmacokinetics, toxicity and impact on metabolism. Toxics. 2023, 11:10.3390\/toxics11120962","journal-title":"Toxics"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8040551","article-title":"Global burden related to nitrous oxide exposure in medical and recreational settings: a systematic review and individual patient data meta-analysis","volume":"8","author":"Oussalah A","year":"2019","unstructured":"Oussalah A, Julien M, Levy J, et al.. Global burden related to nitrous oxide exposure in medical and recreational settings: a systematic review and individual patient data meta-analysis. J Clin Med. 2019, 8:10.3390\/jcm8040551","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.230196","article-title":"Diagnosis and management of toxicity associated with the recreational use of nitrous oxide","volume":"195","author":"De Halleux C","year":"2023","unstructured":"De Halleux C, Juurlink DN. Diagnosis and management of toxicity associated with the recreational use of nitrous oxide. CMAJ. 2023, 195:E1075-81. 10.1503\/cmaj.230196","journal-title":"CMAJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11570-z","article-title":"Comparison of biomarker for diagnosis of nitrous oxide abuse: challenge of cobalamin metabolic parameters, a retrospective study","volume":"270","author":"Grzych G","year":"2023","unstructured":"Grzych G, Deheul S, Gernez E, et al.. Comparison of biomarker for diagnosis of nitrous oxide abuse: challenge of cobalamin metabolic parameters, a retrospective study. J Neurol. 2023, 270:2237-45. 10.1007\/s00415-023-11570-z","journal-title":"J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119882532","article-title":"Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational users","volume":"34","author":"Winstock AR","year":"2020","unstructured":"Winstock AR, Ferris JA. Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational users. J Psychopharmacol. 2020, 34:229-36. 10.1177\/0269881119882532","journal-title":"J Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-021-00352-y","article-title":"Recreational nitrous oxide abuse: prevalence, neurotoxicity, and treatment","volume":"39","author":"Xiang Y","year":"2021","unstructured":"Xiang Y, Li L, Ma X, et al.. Recreational nitrous oxide abuse: prevalence, neurotoxicity, and treatment. Neurotox Res. 2021, 39:975-85. 10.1007\/s12640-021-00352-y","journal-title":"Neurotox Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8801-3","article-title":"No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation","volume":"265","author":"Keddie S","year":"2018","unstructured":"Keddie S, Adams A, Kelso AR, et al.. No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation. J Neurol. 2018, 265:1089-95. 10.1007\/s00415-018-8801-3","journal-title":"J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2019190021","article-title":"Diagnostic approach to intrinsic abnormality of spinal cord signal intensity","volume":"39","author":"Lee MJ","year":"2019","unstructured":"Lee MJ, Aronberg R, Manganaro MS, Ibrahim M, Parmar HA. Diagnostic approach to intrinsic abnormality of spinal cord signal intensity. Radiographics. 2019, 39:1824-39. 10.1148\/rg.2019190021","journal-title":"Radiographics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1791721","article-title":"A practical approach to diagnosing peripheral neuropathies","volume":"45","author":"Jacoby N","year":"2025","unstructured":"Jacoby N, Anziska Y. A practical approach to diagnosing peripheral neuropathies. Semin Neurol. 2025, 45:4-12. 10.1055\/s-0044-1791721","journal-title":"Semin Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1381938","article-title":"Mechanisms and recent advances in the diagnosis and treatment of nitrous oxide-induced peripheral neuropathy: a narrative review","volume":"15","author":"Zou X","year":"2024","unstructured":"Zou X, Yi F, Zhou W, et al.. Mechanisms and recent advances in the diagnosis and treatment of nitrous oxide-induced peripheral neuropathy: a narrative review. Front Neurol. 2024, 15:1381938. 10.3389\/fneur.2024.1381938","journal-title":"Front Neurol"},{"key":"ref12","unstructured":"Laughing gas (Nitrous oxide, N2O). information for professionals in contact with consumers [Article in French]. (2025). https:\/\/www.infodrog.ch\/files\/content\/schadensminderung_fr\/FR_Fiche_Info_Gaz_hilarant_v2025.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457224-nitrous-oxide-induced-myelopathy-a-case-from-french-speaking-switzerland","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:53:39Z","timestamp":1772708019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457224-nitrous-oxide-induced-myelopathy-a-case-from-french-speaking-switzerland"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.104698","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}